Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2026-01-23 @ 12:19 PM
Study NCT ID:
NCT05971251
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-01
First Post:
2023-07-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Addition of Loncastuximab Tesirine to Acalbrutinib , Chronic Lymphocytic Leukemia
Sponsor:
University of Alabama at Birmingham
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Chronic Lymphocytic Leukemia | View |
Keywords: